Yumanity Secures $45,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    790 Memorial Drive Cambridge, MA 02139 USA
  • Company Description
    Yumanity Therapeutics is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The Series A financing will accelerate efforts to advance Yumanity Therapeutics’ proprietary platforms aimed at identifying novel therapies to treat neurodegenerative diseases caused by protein misfolding including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
  • M&A Terms
  • Venture Investor
    Fidelity Management & Research Company
  • Venture Investor
    Redmile Group
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    Biogen Idec
  • Venture Investor
    Dolby Family Ventures

Trending on Xconomy